Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...

Esophageal Varices-I: Introduction

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of open access endoscopy on early diagnosis, treatment and gastrointestinal radiology service.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2009

Same author

Comparison of dual and triple therapy for the eradication of Helicobacter pylori in duodenal ulcer patients.

Annals of Saudi medicine·2007

Same author

An organically modified silicate-based ethanol biosensor.

Analytical biochemistry·2001

Same author

Antibiotic resistance in Helicobacter pylori.

Lancet (London, England)·1999

Same author

Blood coagulability and viper envenomation.

Lancet (London, England)·1986

Same author

Lead poisoning and euthyroid hyperthyroxinaemia.

Lancet (London, England)·1985

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

Primary prophylaxis for bleeding from esophageal varices.

¹Department of Internal Medicine, Armed Forces Hospital, Southern Region, Khamis Mushayt, Saudi Arabia.

Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association

|October 30, 2009

Summary

This summary is machine-generated.

Primary prophylaxis for esophageal varices in liver cirrhosis is crucial. Nonselective beta-blockers effectively prevent bleeding, justifying their use in high-risk patients.

More Related Videos

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

Area of Science:

Gastroenterology
Hepatology
Clinical Medicine

Background:

Esophageal varices affect 30-70% of liver cirrhosis patients.
Variceal bleeding is a serious complication, with a high mortality rate for the first episode (40-50%).
Primary prophylaxis is indicated for high-risk patients, necessitating reliable methods for risk identification.

Purpose of the Study:

To evaluate the efficacy of primary prophylaxis strategies for preventing esophageal variceal bleeding in liver cirrhosis patients.
To identify reliable methods for predicting bleeding risk in patients with esophageal varices.

Main Methods:

Review of endoscopic findings for predicting variceal bleeding.
Assessment of outcomes for primary prophylaxis using portacaval shunts and endoscopic sclerotherapy.
Evaluation of nonselective beta-blockers for preventing variceal bleeding.

Main Results:

Endoscopic findings can identify patients at high risk of future bleeding.
Previous prophylaxis methods like portacaval shunts and endoscopic sclerotherapy yielded disappointing results.
Nonselective beta-blockers demonstrated effectiveness in preventing esophageal variceal bleeding.

Conclusions:

Nonselective beta-blockers are justified for primary prophylaxis to prevent esophageal variceal bleeding in liver cirrhosis.
Identifying high-risk patients through endoscopic findings is essential for effective primary prophylaxis.
Further research may refine risk stratification and treatment strategies for variceal bleeding.